Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2020

Feb 25, 2020

32777_dirs_2020-02-25_4fa9698d-38e3-4dc6-93e6-0f43faae31f3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2020-02-21

Reporting Person: Crockett Nigel (Chief Business Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-21 Employee Stock Option (right to buy) $15.36 A 44757 Acquired 2030-02-21 Common Stock (44757) Direct

Footnotes

F1: This option shall vest one-fourth (1/4) of the total number of shares under option on February 21, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter.